About this trial
The expectation of our study was to explore the efficacy of using hyperbaric oxygen to rescue flap ischaemic necrosis after breast cancer surgery.
Eligibility criteria
Qualifiers
understand the study procedure, participate in the study voluntarily and sign the informed consent form
aged ≥ 18 years and ≤ 60 years, female
ECOG 0-2
patients with The SKIN Score Degree of B-D and The SKIN area of 1-3 in the Clavien-Dindo classification after breast cancer surgery;
Disqualifiers
Contraindications to hyperbaric oxygen therapy: lung disease (severe chronic obstructive airway disease, herpetic lung disease, acute or chronic lung infection, uncontrolled asthma, untreated pneumothorax), history of previous middle ear surgery, middle ear disease (Eustachian tube dysfunction, recurrent episodes of vertigo), eye disease (retinal detachment).
Pregnancy or lactation.
any other condition that the investigators think the patient is unsuitable for participation in the study
Trial design
Treatments tested in this trial
- hyperbaric oxygen therapy and povidone-iodine wet compresses
- wet compresses of povidone-iodine